Supplementary Files
How to Cite
Abstract
Objective: Dyslipidemia is a noticeable cause of morbidity and mortality. The purpose of the study was to analyse the cholesterol and triglyceride levels of patients presenting for lipid profile.
Methods: A total of 9989 participants presenting to Benazir Bhutto Hospital, Rawalpindi, for the Lipid profile assessment were enrolled in this study. The participants were included irrespective of age and gender. Data was retrieved from HMIS for the last 7 years (2015-2022). Enzymatic colourimetric techniques were used to examine the serum levels of total cholesterol and triglycerides. Dyslipidemia was defined based on standard guidelines by the National Cholesterol Education Program Adult Treatment Panel III.
Results: Out of the total of 9989 presented with signs and symptoms of dyslipidemia, 401(4%) were subjects under 19 years of age. Among the adult patients, 4283(44 .7%) were males and 5305 (55.3%) were females. Females have significantly high concentrations of cholesterol median (min-max), 203.25(48-1157) as compared to males, 196.95 (2-924). Mann Whitney, p value= 0.0001. Significant. difference was not observed for the concentrations of triglycerides in both genders (p=0.761) Substantial difference in concentrations of cholesterol and triglycerides was observed in different age groups Kruskal Wallise H 145.09 p –value 0.0001, Kruskal Wallise H 171 51 .09 p –value 0.0001 , respectively.
Conclusion: Highest number of patient with dyslipidemia were observed in age group between 40-52 years. Mean cholesterol level in females were significantly higher as compared to males. Prevalence of isolated hypercholesterolemia and isolated hypertriglyceridemia in our study was 50.3% and 59.9% respectively.
References
Tomeleri CM, Ronque ERV, Silva DRP, Cardoso Júnior CG, Fernandes RA, Teixeira DC, et al. Prevalence of dyslipidemia in adolescents: Comparison between definitions. Revista Portuguesa de Cardiologia. 2015 Feb; 34(2):103–9. https://doi.org/10.1016/j.repc.2014.08.020
Opoku S, Gan Y, Fu W, Chen D, Addo-Yobo E, Trofimovitch D, et al. Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and Prevention Project (CNSSPP). BMC Public Health, 2019 Dec;19 (1):1500. https://doi.org/10.1186/s12889-019-7827-5
Waqar S, Khan H, Ahmed RR. Changes in Lipid Profiles According to Body Mass Index in Individuals Coming to a Tertiary Care Hospital. JIMDC, 2017; 6(2):144-147.
Ghazwani M, Mahmood SE, Gosadi IM, Bahri AA, Ghazwani SH, Khmees RA. Prevalence of Dyslipidemia and Its Determinants Among the Adult Population of the Jazan Region. IJGM, 2023 Sep;Volume 16:4215–26. https://doi.org/10.2147/IJGM.S429462
Ali N, Kathak RR, Fariha KA, Taher A, Islam F. Prevalence of dyslipidemia and its associated factors among university academic staff and students in Bangladesh. BMC Cardiovasc Disord, 2023 Jul 21;23(1):366. https://doi.org/10.1186/s12872-023-03399-1.
Ama Moor VJ, Ndongo Amougou S, Ombotto S, Ntone F, Wouamba DE, Ngo Nonga B. Dyslipidemia in Patients with a Cardiovascular Risk and Disease at the University Teaching Hospital of Yaoundé, Cameroon. International Journal of Vascular Medicine, 2017;2017:1 5. https://doi.org/10.1155/2017/6061306.
Martone AM, Landi F, Petricca L, Paglionico A, Liperoti R, Cipriani MC, et al. Prevalence of dyslipidemia and hypercholesterolemia awareness: results from the Lookup 7+ online project. European Journal of Public Health, 2022 Jun 1;32(3):402–7. https://doi.org/10.1093/eurpub/ckab224
Gu D, Wang D, Zhu Q, Luo L, Zhang T. Prevalence of dyslipidemia and associated factors in sedentary occupational population from Shanghai: a cross-sectional study. Arch Public Health, 2024 Feb 8;82(1):21. https://doi.org/10.1186/s13690-024-01245-0
Al Quran TM, Bataineh ZA, Al-Mistarehi AH, Zein Alaabdin AM, Allan H, Al Qura’an A, et al. Prevalence and Pattern of Dyslipidemia and Its Associated Factors Among Patients with Type 2 Diabetes Mellitus in Jordan: A Cross-Sectional Study. IJGM, 2022 Oct;Volume 15:7669–83. https://doi.org/10.2147/IJGM.S377463.
Qi L, Ding X, Tang W, Li Q, Mao D, Wang Y. Prevalence and risk factors associated with dyslipidemia in Chongqing, China. Int J Environ Res Public Health, 2015 Oct; 12(10):13455–65. https://doi.org/10.3390/ijerph121013455.
Penalva RA, Huoya M de O, Correia LCL, Feitosa GS, Ladeia AMT. Lipid profile and intensity of atherosclerosis disease in acute coronary syndrome. Arq Bras Cardiol, 2008; 90(1):24–30. https://doi.org/0.1590/s0066-782x2008000100005
Zhonghua Xin Xue Guan Bing Za Zhi. Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults. 2007; 35(5):390–419
Pan L, Yang Z, Wu Y, Yin R-X, Liao Y, Wang J, et al. The prevalence, awareness, treatment, and control of dyslipidemia among adults in China. Atherosclerosis, 2016; 248:2–9. https://doi.org/10.1016/j.atherosclerosis.2016.02.006
Toth PP, Potter D, Ming EE. Prevalence of lipid abnormalities in the United States: The National Health and Nutrition Examination Survey 2003-2006. J Clin Lipidol, 2012; 6(4):325–30 . https://doi.org/10.1016/j.jacl.2012.05.002
Zhao W, Zhang J, You Y, Man Q, Li H, Wang C, et al. Epidemiologic characteristics of dyslipidemia in people aged 18 years and over in China. Zhonghua Yu Fang Yi Xue Za Zhi.2005; 39(5):306–10.
Chou R, Dana T, Blazina I, Daeges M, Bougatsos C, Jeanne TL. Screening for dyslipidemia in younger adults: A systematic review for the U.S. preventive services task force. Ann Intern Med. 2016; 165(8):560–4. https://doi.org/10.7326/M16-0946.
Latifi SM, Karandish M, Shahbazian HB, Chinipardaz R, Sabet A, Pirani N. A survey of the incidence of dyslipidemia and its components in people over 20 years old in Ahvaz: A cohort study 2009-2014.Diabetes Metab Syndr. 2017; 11 Suppl 2:S751–4. https://doi.org/10.1016/j.dsx.2017.05.010
Pan L, Yang Z, Wu Y, Yin R-X, Liao Y, Wang J, et al. The prevalence, awareness, treatment, and control of dyslipidemia among adults in China. Atherosclerosis. 2016; 248:2–9. https://doi.org/10.1016/j.atherosclerosis.2016.02.006
Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, et al. Prevalence, awareness, treatment, and control of hypertension in China: Data from the China National Nutrition and Health Survey 2002. Circulation. 2008; 118(25):2679–86. https://doi.org/10.1161/CIRCULATIONAHA.108.788166.
JH, Wang LM, Li YC, Bi YF, Jiang Y, Mi SQ, Dai M, Xu Y, Ning G, Zhao WH. [Epidemiologic characteristics of dyslipidemia in Chinese adults 2010]. Zhonghua Yu Fang Yi Xue Za Zhi. 2012 May;46(5):414-8.
Huang Y, Gao L, Xie X, Tan SC. Epidemiology of dyslipidemia in Chinese adults: a meta-analysis of prevalence, awareness, treatment, and control. Popul Health Metr. 2014; 12(1):28.
Song PK, Man QQ, Hong LI, Pang SJ, Jia SS, Li YQ, Li HE, Zhao WH, Zhang J. Trends in lipids level and dyslipidemia among Chinese adults, 2002-2015. Biomedical and Environmental Sciences. 2019; 1;32(8):559-70. https://doi.org/10.3967/bes2019.074.
Basit A, Sabir S , Riaz M, Asher Fawwad A. NDSP 05: Prevalence and pattern of dyslipidemia in urban and rural areas of Pakistan; a sub analysis from second National Diabetes Survey of Pakistan (NDSP) 2016–2017. J Diabetes Metab Disord. 2020; 19:1215–1225. https://doi.org/10.1007/s40200-020-00631.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2025 Wafa Omer, Alishba Waheed, Huma Amin, Asma Nafisa, Muhammad Umar